Complete Wegovy vs Mounjaro vs Ozempic Cost Breakdown
Wegovy vs Mounjaro vs Ozempic: The Hidden Fee Problem
When researching Wegovy vs Mounjaro vs Ozempic, most patients discover a frustrating reality: advertised prices rarely reflect true costs. Many online pharmacies promote low headline prices, then add consultation fees (£15-£40), prescription charges (£10-£25), and administrative costs at checkout. This pricing opacity makes genuine comparison impossible and forces patients to budget blindly for their weight management journey.
EverydayMeds eliminates this confusion with radical price transparency. Our Wegovy pricing includes every component: the 3-minute clinical assessment, prescriber review by our qualified clinicians, prescription generation, and next-day cold-chain delivery. Whether you're comparing the mechanisms of semaglutide (Wegovy), tirzepatide (Mounjaro), or understanding why Ozempic isn't licensed for weight loss in the UK, you'll know exactly what you're paying upfront.
Complete Wegovy vs Mounjaro vs Ozempic Pricing Comparison
Understanding the true cost of Wegovy vs Mounjaro vs Ozempic requires transparent pricing. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our bundles provide convenience for multi-month supply: the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Ultimate Stability Trio offers three months of 2.4mg maintenance for £649.99. Every price includes clinical assessment, prescriber review, prescription, and delivery.
New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 to reach these final prices. Unlike competitors who charge separate consultation fees, our pricing model ensures no surprises. When comparing Wegovy vs Mounjaro vs Ozempic costs, remember that Ozempic is licensed for type 2 diabetes only - promoting it for weight loss constitutes illegal off-label advertising in the UK.
Clinical Evidence: Wegovy vs Mounjaro vs Ozempic Trial Data
The clinical foundation for Wegovy vs Mounjaro vs Ozempic comparison stems from separate trial programmes with different designs and populations. Wegovy's STEP trials demonstrated that patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed 20% reduction in major cardiovascular events with Wegovy treatment.
Mounjaro's SURMOUNT trials evaluated tirzepatide's dual GIP and GLP-1 receptor mechanism, whilst Ozempic's SUSTAIN programme focused on glycaemic control in diabetes patients. Directly comparing trial percentages between these studies would be misleading due to different endpoints, populations, and methodologies when evaluating Wegovy vs Mounjaro vs Ozempic effectiveness.
How Wegovy Works in the Wegovy vs Mounjaro vs Ozempic Landscape
Understanding Wegovy vs Mounjaro vs Ozempic requires grasping their distinct mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural fullness hormone GLP-1, binding specifically to GLP-1 receptors in the brain's appetite centres. This action reduces appetite, promotes feelings of satiety after smaller meals, and may help reduce food cravings between meals. Mounjaro (tirzepatide) offers dual action by targeting both GIP and GLP-1 receptors, whilst Ozempic uses the same semaglutide molecule as Wegovy but is licensed exclusively for type 2 diabetes management. All three are prescription-only medicines requiring clinical assessment and ongoing medical supervision alongside a reduced-calorie diet and increased physical activity.
Streamlined Ordering Process for Wegovy vs Mounjaro vs Ozempic
Accessing any option in the Wegovy vs Mounjaro vs Ozempic comparison through EverydayMeds follows our transparent three-step process. Complete our 3-minute online clinical assessment covering medical history, current medications, and treatment goals, ensuring suitability for prescription-only weight management therapy. Our qualified prescribers review applications within 3 working days (or 24 hours with express service), determining the most appropriate option based on individual circumstances. Once approved, medications ship via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transport. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance for all Wegovy vs Mounjaro vs Ozempic prescriptions.
Storage and Practical Considerations for Wegovy vs Mounjaro vs Ozempic
Practical differences emerge when comparing Wegovy vs Mounjaro vs Ozempic storage requirements and administration. All three require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability (below 30°C) compared to Mounjaro's 21-day limit. Wegovy utilises Novo Nordisk's FlexTouch pen system with mandatory dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17. Each pen delivers once-weekly injections, typically administered on the same day each week. The MHRA has approved a 7.2mg higher maintenance dose (not yet available at EverydayMeds), whilst Ozempic remains restricted to diabetes treatment regardless of dose strength.
Why Transparent Pricing Matters for Wegovy vs Mounjaro vs Ozempic Decisions
The complexity of Wegovy vs Mounjaro vs Ozempic comparison extends beyond clinical mechanisms to encompass total treatment costs over months or years. Hidden fee structures force patients to make uninformed decisions, potentially choosing based on misleading headline prices rather than true value. Weight management represents a long-term commitment - STEP trial extensions showed patients regained approximately two-thirds of lost weight within one year of stopping treatment.
Transparent pricing enables proper financial planning for sustained therapy. When comparing Wegovy vs Mounjaro vs Ozempic, patients need visibility of escalating dose costs, maintenance pricing, and potential bundle savings. EverydayMeds' upfront pricing model eliminates consultation fee surprises, prescription charge additions, and hidden administrative costs that typically emerge at checkout with competitor pharmacies.
Make Your Wegovy vs Mounjaro vs Ozempic Choice with Confidence
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option aligns with your medical profile and treatment objectives. Start your assessment today using discount code FIRST40 (new customers) or DOSE25 (returning patients) applied at checkout for transparent, all-inclusive pricing. Our clinical team provides ongoing support throughout your weight management journey, ensuring optimal outcomes with your chosen therapy. Visit https://everydaymeds.co.uk/collections/wegovy to begin your consultation, knowing exactly what you'll pay without hidden fees or surprise charges. Weight management success requires the right medication, clinical support, and transparent pricing - EverydayMeds delivers all three.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
